Home/ Supplements/ Vitamin K/ Vitamin K2-7 plus D3

Vitamin K2-7 plus D3

product on market Capsule Just Thrive Safety: 80/100
80/100

This product is generally safe

  • Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
  • 50% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D and MenaquinGold (K2-7) are researched for their roles in supporting bone density and calcium regulation. While these ingredients have strong evidence for efficacy, the overall evidence coverage for this specific formulation is limited. The profile maintains a high safety score of 80/100.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin D: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)

Label

Product Label

Label for Vitamin K2-7 plus D3
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Vitamin
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

125 mcg (625% DV)
Exceeds UL by 1.2× (UL: 0.1 mg) 608 studies (A:16, B:251)
MenaquinGold
200 mcg

Other Ingredients

Cellulose Cellulose Water Maltodextrin Tocopherols Medium Chain Triglyceride
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Ages 18+ take 1 capsule daily with food or as recommended by a healthcare practitioner.

Warnings & Precautions

Caution: Do not exceed recommended dose. Use only if safety seal is intact.

If you are taking anti-coagulant, anti-platelet medications, or have a bleeding disorder, consult with your healthcare provider before taking this product. If you are pregnant or nursing, taking any medication condition, consult with your doctor before using any dietary supplement.

Keep out of reach of children.

Formulation Notes

Vitamin D drives cognitive health, bone health, immune function and more. Vitamin K2 helps your body use calcium properly which impacts cardiovascular health and bone density. Individually they're crucial, but they're even better when paired together. Vitamin K2-7 plus D3 offers high potency K2-7 and D3 for synergistic total body health support.

High potency Supports healthy Immunity Bones Cardiovascular function

Vegetarian

Gluten free Dairy free Non GMO Soy free

MenaquinGold For 100% guaranteed potency

Additional Information

Vitamin Angels Proud Supporter Your purchase helps support the health of a child for an entire year.

Metadata

Product Details

UPC / SKU6 44216 44703 9
DSLD Entry Date2024-11-22
Product TypeVitamin
FormCapsule
DSLD ID319894
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.